VDAC3

Non-selective voltage-gated ion channel VDAC3 · Q9Y277 · VDAC3 on Sugi Atlas →

0 patent compounds predicted against VDAC3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to VDAC3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R PHASE4WITHDRAWN
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women PHASE4COMPLETED
The Re-Prosper HF Study PHASE2/PHASE3COMPLETED
Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN) PHASE3COMPLETED
Desflurane vs. Propofol for Cardiac Anesthesia PHASE3RECRUITING
Role of Intralipid in Management of Organophosphorus Poisoning PHASE2/PHASE3WITHDRAWN
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss PHASE2COMPLETED
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease PHASE2COMPLETED
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder PHASE2WITHDRAWN
StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2 PHASE2RECRUITING
Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival PHASE1UNKNOWN
A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours PHASE1COMPLETED
Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation PHASE1COMPLETED
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases PHASE1COMPLETED
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function PHASE1COMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies nanUNKNOWN
Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases nanUNKNOWN
Mitochondrial Assessment in Critical Ill Patients in Intensive Care nanNOT_YET_RECRUITING
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain. nanUNKNOWN
Metabotropic Receptors For Glutamate Type 3 In Parkinson's nanUNKNOWN
Aging and the Mitochondrial Response to Exercise Training, Measured by Noninvasive 31P Magnetic Resonance Spectroscopy nanCOMPLETED
Vacuolar ATPase and Drug Resistance of High Grade Gliomas nanUNKNOWN
Identify the Genes Polymorphisms Related to Non-familial Bradyarrhythmia nanUNKNOWN
Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) in Ischaemic, Inflammatory and Takotsubo Cardiomyopathy (MEMORY) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a VDAC3 binder may also engage these)

ProteinNameSimilarity
Q5R7V4 1.000 Q5R7V4 →
Q9TT13 1.000 Q9TT13 →
Q60931 1.000 Q60931 →
Q9MZ13 1.000 Q9MZ13 →
Q29380 0.999 Q29380 →
Q9R1Z0 0.990 Q9R1Z0 →
P81004 0.988 P81004 →
P81155 0.978 P81155 →
P82013 0.977 P82013 →
VDAC2 Non-selective voltage-gated ion channel VDAC2 0.976 landscape →
Q60930 0.976 Q60930 →
P68002 0.971 P68002 →
P86223 0.971 P86223 →
P42055 0.971 P42055 →
Q9MZ15 0.968 Q9MZ15 →
P68003 0.968 P68003 →
P46274 0.967 P46274 →
Q60932 0.965 Q60932 →
P42054 0.965 P42054 →
P42056 0.963 P42056 →
Q9SRH5 0.963 Q9SRH5 →
Q9SMX3 0.954 Q9SMX3 →
Q6L5I5 0.953 Q6L5I5 →
Q7F4F8 0.952 Q7F4F8 →
P07144 0.951 P07144 →
Q9Z2L0 0.949 Q9Z2L0 →
Q84P97 0.948 Q84P97 →
VDAC1 Non-selective voltage-gated ion channel VDAC1 0.941 landscape →
P42057 0.940 P42057 →
J5JPV3 0.939 J5JPV3 →